±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1122  |  »Ø¸´: 9
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßzhaoyongqiangÔö¼Ó½ð±Ò 1.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


[×ÊÔ´] Reversed Phase Chromatography(ÍâÎÄÊé¼®)

ÏÂÔØµØÖ·http://www.namipan.com/d/Reverse ... 3e9f7057b6b0c7e0800

Contents
1. Introduction ..............................................................................................5
Theory of reversed phase chromatography ...............................................6
The matrix ................................................................................................9
The ligands ............................................................................................. 11
Resolution in reversed phase chromatography ........................................ 13
Resolution .............................................................................................. 13
Capacity factor ....................................................................................... 14
Efficiency ................................................................................................ 15
Selectivity ................................................................................................ 17
Binding capacity ..................................................................................... 18
Critical parameters in reversed phase chromatography........................... 19
Column length ...................................................................................19
Flow rate ............................................................................................19
Temperature ....................................................................................... 20
Mobile phase ..................................................................................... 20
Organic solvent .................................................................................. 20
Ion suppression .................................................................................. 21
Ion pairing agents .............................................................................. 22
Gradient elution ................................................................................. 23
Mode of use ............................................................................................24
Desalting ............................................................................................24
High resolution separations ............................................................... 25
Large scale preparative purification ................................................... 25
Stages in a purification scheme .......................................................... 26
Capture .............................................................................................. 26
Intermediate stages .............................................................................27
Polishing ............................................................................................27
2. Product Guide .........................................................................................29
SOURCE™ RPC ..................................................................................... 30
Product description ............................................................................ 30
High chemical stability ...................................................................... 32
Excellent flow/pressure characteristics ................................................ 34
High capacity ..................................................................................... 35
Availability ........................................................................................ 36
¦ÌRPC C2/C18 .........................................................................................37
Product description ............................................................................ 37
Chemical and physical stability .......................................................... 38
Flow/pressure characteristics ..............................................................38
Capacity ............................................................................................38
Availability ........................................................................................ 39
Sephasil™ Protein/Sephasil Peptide ......................................................... 39
Product description ............................................................................ 39
Chemical and physical stability .......................................................... 40
Flow/pressure characteristics ..............................................................40
Availability ........................................................................................ 40
3. Methods ................................................................................................. 41
Choice of separation medium .................................................................41
Unique requirements of the application .............................................. 41
Resolution .......................................................................................... 41
Scale of the purification ..................................................................... 42
Mobile phase conditions ....................................................................42
Throughput and scaleability ..............................................................42
Molecular weight of the sample components ......................................42
Hydrophobicity of the sample components ........................................ 43
Class of sample components ..............................................................43
Choice of mobile phase ........................................................................... 44
The organic solvent ............................................................................ 44
pH .....................................................................................................46
Ion pairing agents .............................................................................. 47
Sample preparation................................................................................. 49
Mobile phase preparation .......................................................................50
Storage of mobile phase ..................................................................... 50
Solvent disposal ................................................................................. 50
Detection ................................................................................................ 51
Ghosting ............................................................................................51
Mobile phase balancing ..................................................................... 51
Column conditioning .............................................................................. 52
Elution conditions ...................................................................................53
Column re-equilibration ......................................................................... 55
Column cleaning ..................................................................................... 55
Column storage ......................................................................................56
4. Applications............................................................................................57
Designing a biochemical purification ...................................................... 57
Naturally occurring peptides and proteins .............................................. 58
Purification of platelet-derived growth factor (PDGF) ........................ 59
Trace enrichment ............................................................................... 59
Purification of cholecystokinin-58 (CCK-58) from pig intestine ......... 60
Recombinant peptides and proteins ........................................................62
Process purification of inclusion bodies .............................................. 63
Purification of recombinant human epidermal growth factor ............. 63
Chemically synthesised peptides..............................................................65
Purification of a phosphorylated PDGF a-receptor derived peptide .... 65
Structural characterisation of a 165 kDa protein ............................... 66
Protein fragments from enzyme digests ................................................... 66
Protein characterisation at the micro-scale .........................................66
Protein identification by LC-MS ......................................................... 69
Chemically synthesised oligonucleotides ................................................. 70
5. Fault finding chart .................................................................................. 72
6. References ...............................................................................................81
7. Ordering information .............................................................................84

[ Last edited by zhaoyongqiang on 2008-3-17 at 12:07 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by ruyibaobei at 2008-3-17 12:34:
ºÃ¶«¶«

¼ûÊéÆÀÌû¡­¡­
7Â¥2008-03-18 15:35:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


¡¾ÆÀ¼Û¡¿  ¡ï¡ï¡ï¡ï¡ï (ÎåÐǼ¶,ÓÅÐãÍÆ¼ö)

¼ûÊéÆÀÌû¡­¡­
4Â¥2008-03-17 12:03:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

weifengnit

ľ³æ (ÕýʽдÊÖ)


Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£
5Â¥2008-03-17 13:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
8Â¥2008-03-19 14:50:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-03-17 15:01   »Ø¸´  
ÒýÓûØÌû:
Originally posted by weifengnit at 2008-3-17 13:48: Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£

¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +20 kikiki7 2026-03-30 20/1000 2026-04-03 01:19 by BruceLiu320
[¿¼ÑÐ] 312 »¯¹¤»òÖÆÒ©µ÷¼Á +7 ССī123 2026-04-02 8/400 2026-04-02 22:15 by ZXlzxl0425
[»ù½ðÉêÇë] ÇëÎʹ²Í¬Í¨Ñ¶ºÍ¹²Í¬Ò»×÷µÄÈϿɶÈÎÊÌâ 10+4 psa1234 2026-04-01 9/450 2026-04-02 22:03 by god_tian
[¿¼ÑÐ] ²ÄÁÏ340·Öµ÷¼Á +7 ÏÄÒ¹Íí·ç_long 2026-04-02 9/450 2026-04-02 21:20 by dongzh2009
[¿¼ÑÐ] µ÷¼ÁÇóÖú +8 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 8/400 2026-04-02 20:47 by dongzh2009
[¿¼ÑÐ] Àíѧ07»¯Ñ§ 303Çóµ÷¼Á +16 î£08 2026-03-27 17/850 2026-04-02 13:29 by Æß¶È²»ÐÅÈÎ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +9 Ë«ÂíβƦÀϰå2 2026-04-01 9/450 2026-04-02 12:14 by oooqiao
[¿¼ÑÐ] 307·ÖÇóµ÷¼Á +14 (o~o) 2026-03-31 15/750 2026-04-01 20:43 by longlotian
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì339Çóµ÷¼Á +11 hyz0119 2026-03-31 12/600 2026-04-01 18:40 by ΰ´óºÓ±±
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +9 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 9/450 2026-04-01 14:30 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò© ³õÊÔ274Çóµ÷¼Á +5 С¶£µ±À´ÁË 2026-03-30 6/300 2026-04-01 14:25 by mxj1203
[¿¼ÑÐ] 329Çóµ÷¼Á£¬Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬²ÄÁϹ¤³Ì£¨085601£© +6 СС»úÁ鳿 2026-03-29 12/600 2026-03-31 16:58 by ¼Çʱ¾2026
[¿¼ÑÐ] 293·ÖÇóµ÷¼Á£¬ÍâÓïΪ¶íÓï +5 ¼ÓÒ»Ò»¾Å 2026-03-31 5/250 2026-03-31 09:39 by zhshch
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ³õÊÔ346 +4 085601³õÊÔ346 2026-03-30 4/200 2026-03-31 07:47 by jp9609
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
[¿¼ÑÐ] 105500ҩѧÇóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧҩѧ£¬348·Ö +3 gr¹þ¹þ¹þ 2026-03-28 3/150 2026-03-30 18:56 by Ô´_2020
[¿¼ÑÐ] 332Çóµ÷¼Á +6 @MZB382400 2026-03-28 6/300 2026-03-30 16:57 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 071010 323 ·ÖÇóµ÷¼Á +3 Baekzhy 2026-03-27 3/150 2026-03-30 14:24 by andresqi
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ²ÄÁÏѧ˶Çóµ÷¼Á +3 @taotao 2026-03-28 3/150 2026-03-28 10:26 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û